Fundraising FoxNew Leaf Venture Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Founder)
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Board seatVijay Lathi· per SEC Form D · $16.8M raise · filed Mar 2022
Co-investorsBattery VenturesBreyer CapitalCatalytic Impact FoundationDigiTx Partners LLCEsplanade VenturesInsight Partners+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.